BREZTRI Drug Patent Profile
✉ Email this page to a colleague
When do Breztri patents expire, and what generic alternatives are available?
Breztri is a drug marketed by Astrazeneca Ab and is included in one NDA. There are nine patents protecting this drug.
The generic ingredient in BREZTRI is budesonide; formoterol fumarate; glycopyrrolate. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the budesonide; formoterol fumarate; glycopyrrolate profile page.
DrugPatentWatch® Generic Entry Outlook for Breztri
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BREZTRI?
- What are the global sales for BREZTRI?
- What is Average Wholesale Price for BREZTRI?
Summary for BREZTRI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for BREZTRI |
| What excipients (inactive ingredients) are in BREZTRI? | BREZTRI excipients list |
| DailyMed Link: | BREZTRI at DailyMed |
US Patents and Regulatory Information for BREZTRI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | BREZTRI AEROSPHERE | budesonide; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 212122-001 | Jul 23, 2020 | RX | Yes | Yes | 8,815,258 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca Ab | BREZTRI AEROSPHERE | budesonide; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 212122-001 | Jul 23, 2020 | RX | Yes | Yes | 9,463,161 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Astrazeneca Ab | BREZTRI AEROSPHERE | budesonide; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 212122-001 | Jul 23, 2020 | RX | Yes | Yes | 8,324,266 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca Ab | BREZTRI AEROSPHERE | budesonide; formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 212122-001 | Jul 23, 2020 | RX | Yes | Yes | 11,833,292 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
